Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Paola Fisicaro; Caterina Valdatta; Marco Massari; Elisabetta Loggi; Lara Ravanetti; Simona Urbani; Tiziana Giuberti; Albertina Cavalli; Carmen Vandelli; Pietro Andreone

doi:10.1053/j.gastro.2012.08.041

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Identifier:nobleid.org/w1/20260515/CDF71EA4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CDF71EA4.svg?ark=w1%2F20260515%2FCDF71EA4)](https://nobleid.org/work/w1/20260515/CDF71EA4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Identifier:nobleid.org/w1/20260515/CDF71EA4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CDF71EA4.svg?ark=w1%2F20260515%2FCDF71EA4)](https://nobleid.org/work/w1/20260515/CDF71EA4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work